引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 2067次   下载 879 本文二维码信息
码上扫一扫!
Kinesin家族成员 C1促进结肠癌细胞增殖及与预后的相关分析
李冰,陈靖,于素香,朱凤池,闫江鹤,赵秀娟,冯璞,陈苗凤,贾金娜
保定市第四中心医院河北保定 072350;天津市肿瘤医院胰腺肿瘤科天 津 300060;保定市第二医院肛肠外科河北保定 071052
摘要:
目的:探讨 Kinesin家族成员 C1(KIFC1)在结肠腺癌中的表达及其与病理特征、临床分期、预后的相关性。方法:选取 2012年 1月—2018年 12月保定第四中心医院、天津市肿瘤医院和保定第二医院肛肠外科收治的 122例结肠腺癌。应用免疫组化染色方法检测结肠腺癌及癌旁组织中 KIFC1蛋白的表达,分析结肠癌患者的 KIFC1表达与临床病理特征的关系,并通过 Kaplan-Meier方法分析 KIFC1表达水平对患者总生存期和无进展生存期的影响;利用 shRNA分别敲低结肠癌细胞系 HCT116和 HT29中的 KIFC1表达水平,应用 MTT和克隆形成实验评估 KIFC1对于结肠癌细胞增殖作用的影响。结果:免疫组化结果显示,在 122例结肠腺癌标本中, 62例 KIFC1蛋白低表达, 60例 KIFC1蛋白高表达。 KIFC1蛋白高表达与结肠腺癌 T分期及临床分期具有相关性( P=0.040、P=0.047);Kaplan-Meier分析发现, KIFC1高表达组患者总生存期和无进展生存期较低( P=0.0004、P<0.0001)。体外细胞实验结果表明,敲低 KIF1C可显著下调增殖相关蛋白 Ki67和 PCNA的表达水平( P<0.05),降低结肠癌细胞增殖能力和集落形成数( P<0.05)。结论: KIFC1蛋白在结肠腺癌组织中高表达,并且与结肠腺癌临床分期及患者的不良预后相关;低表达 KIFC1抑制结肠癌细胞增殖。
关键词:  Kinesin家族成员 C1  结肠腺癌  临床特征  不良预后
DOI:10.3969/j.issn.1007-6948.2022.06.021
投稿时间:2022-01-11
基金项目:国家自然科学基金青年基金(81401957)
Kinesin Family Member C1 Promotes Proliferation of Colon Cancer Cells and its Correlation with Prognosis
LI Bing,CHEN Jing,YU Su-xiang
Abstract:
Objective To investigate the expression of KIFC1 in colon adenocarcinoma and its relationship with the clinicopathologic features and the prognosis of patients undergoing radical colectomy. Methods  Immunohistochemical staining was used to analyze the expression of KIFC1 protein in 122 samples of colon adenocarcinoma and paracancer from January 2012 to December 2018 in the Baoding fourth central hospital, Tianjin tumor hospital and Baoding second hospital. According to the level of KIFC1 expression in colon adenocarcinoma samples, patients were divided into KIFC1 high expression group and KIFC1 low expression group. Clinical data related to the perioperative clinical features (age, gender, tumor T stage, differentiation level, clinical stage and lymph node metastasis), the correlation of KIFC1 expression and clinical features were analyzed, and the disease overall survival and progression-free survival of the two groups were analyzed by Kaplan-Meier method. The expression level of KIFC1 in colon cancer cell lines HCT116 and HT29 was knocked down by shRNA, and the effects of KIFC1 on the proliferation level of colon cancer cells lines were evaluated by MTT assay, colony formation assay, and detection of Ki67 and PCNA levels. Results Immunohistochemical results showed that among the 122 specimens of colon adenocarcinoma, 62 of them had low expression at protein level of KIFC1 and 60 samples showed high KIFC1 expression at protein level. High expression of KIFC1 level of KIFC1 and 60 samples showed high KIFC1 expression at protein level. High expression of KIFC1 was related with higher colon adenocarcinoma Tstage (P =0.040) and higher clinical stage (P =0.047).Patients with high expression of KIFC1 had poor overall survival and disease-free survival by using Kaplan-Meier analysis (P =0.0004 and P <0.0001 respectively). The colon cancer cell lines stably knocked down KIFC1 were established in vitro. MTT, cloning and proliferation-related protein assay showed that the cell proliferation rate decreased significantly (P <0.05), the number of colony formation decreased significantly(P <0.05), and the expression levels of proliferation-related protein Ki67 and PCNA decreased significantly(P <0.05). Conclusion KIFC1 protein is abnormally highly expressed in colorectal adenocarcinoma specimens, which is associated with high clinical staging of colorectal adenocarcinoma, leading to poor prognosis of patients. At the same time, KIFC1 has been proved to be able to regulate the proliferation of colon cancer cell lines, therefore, KIFC1 may become a new factor and therapeutic target for colon adenocarcinoma patients.
Key words:  Kinesin family member C1  colorectal adenocarcinoma  clinical characteristics  poor prognosis

用微信扫一扫

用微信扫一扫